Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours Jeffrey CummingsJohn F. Smyth Review Pages: 269 - 272
Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro Guy G. ChabotMarie-Christine BisseryAlain Gouyette Original Articles Pages: 273 - 276
Preclinical pharmacologic studies of the new antitumor agent carmethizole (NSC-602668) in the mouse and beagle dog Joanne I. BrodfuehrerTracy J. WilkeGarth Powis Original Articles Pages: 277 - 283
Identification of anthracyclines and related agents that retain preferential activity over Adriamycin in multidrug-resistant cell lines, and further resistance modification by verapamil and cyclosporin A Helen M. ColeyPeter R. TwentymanPaul Workman Original Articles Pages: 284 - 290
Prediction of thioguanine-induced cytotoxicity by dual-parameter flow cytometric analysis Jonathan MaybaumPaul TingClare E. Rogers Original Articles Pages: 291 - 294
Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing Christopher H. J. FordVernon J. RichardsonGeorgia Tsaltas Original Articles Pages: 295 - 301
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCa mammary carcinoma Gianni SavaSonia ZorzetGrazia Zassinovich Original Articles Pages: 302 - 306
Differential interactions of traditional and novel antiemetics with dopamine D2 and 5-hydroxytryptamine3 receptors Anne HamikStephen J. Peroutka Original Articles Pages: 307 - 310
Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol Etel InstitórisKároly SziklaFerenc Gál Original Articles Pages: 311 - 313
A phase I trial of trimetrexate glucuronate (NSC 352122) given every 3 weeks: clinical pharmacology and pharmacodynamics Louise B. GrochowDennis A. NoeRoss C. Donehower Original Articles Pages: 314 - 320
Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer R. L. SouhamiH. T. HajichristouJ. S. Tobias Original Articles Pages: 321 - 325
Alternating six-drug combination chemotherapy induction for intermediate and high-grade non-Hodgkin's lymphoma John A. GreenR. Douglas ErringtonHilmar M. Warenius Original Articles Pages: 326 - 328
The effect of dose on the bioavailability of oral etoposide: confirmation of a clinically relevant observation Maurice L. SlevinSimon P. JoelPeter F. M. Wrigley Original Articles Pages: 329 - 331
Pharmacokinetic and pharmacodynamic studies with 4′-epi-doxorubicin in nasopharyngeal carcinoma patients Oliver Yoa-Pu HuShiu-Pei ChangKuang-Yao Chen Original Articles Pages: 332 - 337
VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen R. HerbrechtJ. J. GarciaF. Oberling Short Communication Pages: 338 - 339